Bharat Biotech mulls booster dose six months after second shot of COVID-19 vaccine

The company is studying administration of a booster dose in a separate Phase-2 trial. It has approached the Subject Expert Committee (SEC) under India's drug regulator with a proposal to administer the booster dose after six months of the second dose.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dvmg0i
via IFTTT